First oxytocin Active Pharmaceutical Ingredient (API) prequalified
M
News
Product Recall - Moxifloxacin 100mg Dispersible Tablets (TB342): Batch BMC5801A
M
On 28 May 2019, Macleods Pharmaceutical Ltd.
Sun’s abacavir/lamivudine tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Mylan’s darunavir 600mg and 800mg tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Unique’s ciprofloxacin tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Krka’s darunavir 600mg tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Macleods’ streptomycin injection prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
First generic daclatasvir prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Macleods’ amodiaquine/artesunate tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
MSN’s levofloxacin tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Micro Labs’ lamivudine/nevirapine/zidovudine tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Information on the GMP status of Micro Labs Kumbalgodu (ML08) manufacturing facility
M
A Good Manufacturing Practice (GMP) inspection of Micro Labs Ltd., Kumbalgodu (ML08) was carried out by the World Health Organization 27-31 August 2018.
First mebendazole prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Cipla’s dolutegravir/lamivudine/tenofovir tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Mylan’s sulfamethoxazole/trimethoprim tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Frequently Asked Questions (FAQ) - WHO Pilot Procedure for Prequalification of Biotherapeutic Products: rituximab and trastuzumab
M
This is the first Q&A on biotherapeutic/similar biotherapeutic products (BTP/SBP) based on the experience of rituximab and trastuzumab applications in the ongoing BTP/SBP pilot prequalification
9th Invitation to manufacturers of reproductive health products to submit an expression of interest (EOI) for product evaluation to the WHO Prequalification Team: medicines
M
The following products were added:
Getz’ moxifloxacin tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
PT Kalbe Farma’s levofloxacin tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
6th Invitation to Manufacturers of Medicinal Products for Treatment of Neglected Tropical Diseases, to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Team: medicines
M
The 6th NTD EOI adds fexinidazole for Human African trypanosomiasis (HAT) and clarifies the scabies indication for ivermectin.
First sofosbuvir/velpatasvir prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Strides' artemether/lumefantrine tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Livzon’s kanamycin solution for injection prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Celltrion’s linezolid tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
16th Invitation to manufacturers and suppliers of medicinal products for HIV infections and related diseases to submit and Expression of Interest (EOI) for product evaluation to the WHO Prequalification Team: medicines
M
The following products were deleted:
Mylan’s kanamycin prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Beximco’s lamivudine tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
First FDC with dolutegravir prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list: